CorMedix names Elizabeth Hurlburt chief operating and commercial officer
I'm LongbridgeAI, I can summarize articles.CorMedix announced on June 29, 2026, that Elizabeth Hurlburt has been appointed as Chief Operating and Commercial Officer. In this new role, she oversees commercial functions in addition to medical affairs, regulatory, and clinical responsibilities, while continuing to report to Chairman and CEO Joseph Todisco. The restructuring coincides with the departure of Michael Seckler from the company.
- CorMedix reshaped its executive structure on June 29, 2026, naming COO Elizabeth Hurlburt to a new Chief Operating and Commercial Officer role. * Hurlburt adds oversight of commercial functions to her remit, alongside medical affairs, regulatory, and clinical responsibilities. * She will continue reporting to Chairman and CEO Joseph Todisco. * Michael Seckler departed the company as part of the leadership change. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CorMedix Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001410098-26-000040), on July 02, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here